Tuesday, May 19, 2026
Today's Print

Tag: Covaxin

FDA approves use of Bharat anti-virus vax

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 11.0px; font: 12.0px 'Myriad Pro'} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; text-indent: 9.0px; line-height:...

Taguig opens 4th, 5th vaccination sites in city

Taguig City continues to strengthen its vaccination program as it opened its 4th and 5th vaccination sites in Maharlika Elementary School in Barangay Maharlika...

India vaccines

Entrepreneurial advocacy group Go Negosyo holds a briefing with a number of private companies on COVID-19 vaccine Covaxin, manufactured by India’s Bharat Biotech. Around...

Taguig prepares ‘portfolio of vaccines’ to inoculate residents

The Taguig City government is preparing a portfolio of vaccines that will complement the national government supply and ensure each resident will receive free...

Bharat Biotech’s Covaxin Phase 3 interim efficacy at 81%

The Phase 3 clinical trial results of Bharat Biotech's coronavirus vaccine candidate, Covaxin, yielded an 81 percent interim efficacy in India. "Covaxin demonstrated 81 percent...

India hails ‘life saving’ vaccine

India’s COVID-19 vaccination drive had a successful start with more than 190,000 people receiving their first jabs and no one hospitalized for major side...
- Advertisement -spot_img
- Advertisement -spot_img